Monday, 27 July 2026 · World
USD/EUR 0.878 USD/GBP 0.7495 USD/JPY 163.7 USD/CNY 6.778 All rates →
RSS
EUROS The World Financial Report
Nº 16 Monday, 27 July 2026 · World Edition
LATEST
Asia

Dr Lal Path Labs shares soar 8% after Q1 earnings beat estimates. What Nomura, Nuvama, other brokerages are saying?

Markets-Economic Times · 1h ago · 🇮🇳 India
Dr Lal Path Labs shares soar 8% after Q1 earnings beat estimates. What Nomura, Nuvama, other brokerages are saying?

Dr Lal Path Labs shares surged after a strong Q1FY27 earnings beat, driven by higher realisations and price hikes. Brokerages including Nomura, Nuvama and JM Financial raised target prices, citing robust growth outlook, network expansion and improving margins, with continued momentum expected from diagnostics demand and strategic investments.

Read the full story at Markets-Economic Times →